Indeed, the ectodomain of LRIG1 can be shed from full-length LRIG1 after proteolytic cleavage both in vitro and in vivo [23] and recombinant LRIG1 ectodomain has been demonstrated to suppress tumor growth in a mouse glioma model [25]. The gene discussed is LRIG1; the disease is central nervous system cancer.